跳至主要内容
临床试验/NCT05264077
NCT05264077尚未招募早期 1 期

Efficacy of Dexmedetomidine Versus Midazolam for Early Extubation in Critically Ill Agitated Patients Undergoing Weaning

Sheikh Zayed Medical College0 个研究点目标入组 66 人开始时间: 2024年11月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
早期 1 期
状态
尚未招募
入组人数
66
主要终点
Effective sedation in icu patients lead to successful 1weaning in icu patients

研究概览

简要总结

Comparison of effect of dexmedetomidine and midazolam in icu patients who put on mechanical ventilation and show agitation on weaning.Selection of better agent minimises the drug related side effects like respiratory depression but also helps in weaning for early extubation,give hemodynamic stability and reduce morbidity and mortality in icu..

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Health Services Research
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • all patients with age <60 irrespective of gendre

排除标准

  • Patients who refuse to give consent, severely altered conscious level (GCS < 8/15), traumatic injury causing hypoxemia e.g., severe head / chest / facial trauma or pneumothorax, severe pneumonia, arrhythmia, impaired hearing or blindness, severe hepatic or renal disease, on neuromuscular blocking agents, recent myocardial infarction, use of anti-psychotics, hypersensitivity to any of the drug under study.

研究组 & 干预措施

Dexmedetomidine

Experimental

Inj.Dexmedetomidine(precidex ) 200mcg/2ml Given to participants in infusion form for 24 hours

干预措施: Dexmedetomidine Hydrochloride (Drug)

Midazolam

Experimental

Inj.midazolam 5mg/ml given to participants in infusion form for 24 hrs

干预措施: Dexmedetomidine Hydrochloride (Drug)

结局指标

主要结局

Effective sedation in icu patients lead to successful 1weaning in icu patients

时间窗: Upto 48 hrs

Assess patients by using ramsay sedation score (score 1 =awake upto score 6=no response)

次要结局

未报告次要终点

研究者

申办方类型
Other Gov
责任方
Principal Investigator
主要研究者

Momal Jaleel Khan

Dr.Momal jaleel khan

Sheikh Zayed Medical College

相似试验